Global protein labelling market was valued at $3.0 billion in 2025 and is growing at a CAGR of 10.2% during the forecast period (2026-2035). The market growth is driven by soaring R&D in proteomics, personalized medicine, and drug discovery, fueled by advanced tech like fluorescent/biotin probes, mass spec, and biochips, though high reagent costs and a shortage of skilled professionals pose challenges. Key drivers include rising healthcare spending, increased cancer/chronic disease prevalence, and technological innovation (bioorthogonal/enzymatic methods), with North America leading and Asia-Pacific growing fastest, while companies like Thermo Fisher, Merck, and PerkinElmer dominate.

North America smart highway market was valued at $30.5 billion in 2025 and is projected to reach $164.7 billion by 2035, growing at a CAGR of 18.5% during the forecast period (2026–2035). The growing number of pilot projects, along with the rising adoption of connected and autonomous vehicles, is significantly driving the demand for the North American smart highway market. For instance, Driverless semi?trucks are now being tested or operated on the SH 130 Smart Freight Corridor in central Texas, supported by smart infrastructure enhancements in partnership with TxDOT and Cavnue.

North America optical interconnect market was valued at $7.0 billion in 2025 and is projected to reach $20.4 billion by 2035, growing at a CAGR of 14.3% during the forecast period (2026–2035).The escalation of 5G and edge computing is becoming a major growth driver for North America’s optical interconnect market. As of year-end 2024, the United States and Canada together account for more than 182 million 5G connections, representing a nearly 20% year-over-year growth rate.   To ensure the speed of 10 Gbps, telecom operators are switching from traditional copper and microwave links with high-capacity optical fiber.

North America dental care equipment market was valued at $3,062.3 million in 2025 and is projected to reach $5,310.7 million by 2035, growing at a CAGR of 5.7% during the forecast period (2026–2035). Dental care equipment includes a wide range of technologies used in preventive, diagnostic, and therapeutic dental procedures, such as dental chairs and units, imaging systems (intraoral and extraoral X-ray, CBCT), lasers, CAD/CAM systems, handpieces, and sterilization equipment. Market growth is driven by the high prevalence of dental disorders, increasing demand for cosmetic and restorative dentistry, strong adoption of advanced dental technologies, and favorable reimbursement and insurance coverage across the United States and Canada.

Global transdermal skin patches market was valued at $5,882.0 million in 2025 and is projected to reach $9,107.5 million by 2035, growing at a CAGR of 4.5% during the forecast period (2026-2035). The growing demand for non-invasive drug delivery systems is supported by rising chronic disease prevalence and government-recognized healthcare priorities. Governments and health agencies are increasingly advocating for treatment pathways that improve patient compliance and reduce healthcare burden, particularly for long-term conditions such as cardiovascular disease, diabetes, and chronic pain, which account for a significant proportion of global morbidity. Transdermal patches deliver controlled, sustained medication through the skin, offering a practical substitute for oral or injectable routes and addressing concerns about side effects and adherence. These systems improve drug delivery precision and patient comfort, particularly among elderly populations or those on multiple medications, which is increasingly reflected in public health strategies aimed at managing long-term illnesses and reducing hospital visits.

Global tennis ball machine market was valued at $166.1 million in 2025 and is growing at a CAGR of 4.4% during the forecast period (2026-2035). Sports clubs play a significant role in the adoption and utilization of tennis ball machines, as these facilities focus on structured training, player development, and efficient use of coaching resources. Tennis ball machines help clubs deliver consistent practice sessions by enabling repetitive stroke training, footwork drills, and controlled ball placement for players of different skill levels. It supports both individual and group training, allowing coaches to manage larger numbers of athletes while maintaining training quality. Additionally, ball machines are used in clubs for junior development programs, performance enhancement, and off-peak practice, improving court utilization and overall training efficiency.

Rooftop solar panel market was valued at $41.2 billion in 2025 and is projected to reach $78.5 billion by 2035, growing at a CAGR of 6.8% during the forecast period (2026-2035). Rooftop solar is emerging as a central driver of change in the global solar panel market, supported by the shift toward distributed energy systems and on-site power generation. Rising electricity costs, grid reliability concerns, and space constraints in urban areas are accelerating adoption across both household and corporate sectors. Corporate users, in particular, are using rooftop installations to manage long-term energy costs and meet internal sustainability targets, while households are increasingly adopting rooftop systems to reduce dependence on centralized power supply. This momentum is directly influencing demand across panel types, with monocrystalline and polycrystalline silicon panels seeing strong uptake due to efficiency and space optimization needs in rooftop settings.

Global pharmacy automation market was valued at $6.5 billion in 2025 and is growing at a CAGR of 8.0% during the forecast period (2026-2035). The rising demand for automated pharmacy solutions is being driven by the growing emphasis on value-based care, medication adherence, and improved therapy outcomes. Healthcare organizations are increasingly seeking systems that integrate clinical analytics, AI, and decision support to optimize medication management, reduce errors, and lower overall healthcare costs. These trends are directly contributing to the growth of the global pharmacy automation market, as automated solutions enable efficient dispensing, monitoring, and management of complex therapies across large patient populations.

Global dysmenorrhea treatment market was valued at $2,115.3 million in 2025 and is projected to reach $4,579.4 million by 2035, growing at a CAGR of 8.1% during the forecast period (2026-2035). The heavy reliance on NSAIDs for managing menstrual pain, combined with their well-documented safety limitations, is a major driver shaping innovation and demand in the market. Dysmenorrhea is primarily mediated by excess prostaglandin production, making NSAIDs the first-line therapy across both primary and secondary dysmenorrhea. Its widespread use reflects the scale of unmet need, with an estimated 30 billion NSAID doses consumed annually in the US alone. However, long-term and recurrent NSAID use is associated with gastrointestinal injury, bleeding risk, and cardiovascular, renal, and hepatic complications. These risks are particularly relevant in dysmenorrhea, where patients often require repeated monthly dosing over several years. 

Jet injector market was valued at $190.3 million in 2025 and is expected to reach $346.7 million by 2035, expanding at a CAGR of 6.2% over the 2026–2035 forecast period. Rising industry investment and expanding clinical validation are emerging as a central driver for the jet injector market. Pharmaceutical companies and device developers are scaling needle-free platforms to improve vaccine delivery, enhance drug performance, and address injection hesitancy at the point of care. As these systems demonstrate faster workflows, simplified training, and compatibility with existing clinical practices, jet injectors are moving from niche use cases into mainstream immunization and therapeutic programs. This shift is strengthening adoption across vaccine delivery, insulin administration, and other applications, while reinforcing demand from pharmaceutical companies, hospitals, and clinical centres seeking safer, more efficient delivery alternatives.